Liabilities / Assets
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
99th percentile
Higher net margin than 99% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
$296,513
No earlier filing loaded for comparison.
Net Assets
$296,513
No earlier filing loaded for comparison.
Liabilities
$0
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
$297,522
No earlier filing loaded for comparison.
Expenses
$1,009
No earlier filing loaded for comparison.
Net Income
$296,513
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview
Mission
To support the research and development of treatments and cures for complications related to neurofibromatosis type 1.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $296,513
- Liabilities
- $0
- Net assets
- $296,513
- Revenue
- $297,522
- Expenses
- $1,009
- Net income
- $296,513